Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
$0.51
+8.5%
$0.42
$0.29
$1.43
$16.00M-0.21183,444 shs77,305 shs
BioCorRx Inc. stock logo
BICX
BioCorRx
$0.78
$1.00
$0.67
$2.22
$6.94M0.591,315 shsN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$0.27
+4.8%
$0.23
$0.14
$2.38
$6.65M1.27814,590 shs122,123 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$0.09
+0.2%
$0.11
$0.05
$1.47
$6.36M1.62373,075 shs206,958 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
+6.14%+7.55%-5.37%-7.07%-55.35%
BioCorRx Inc. stock logo
BICX
BioCorRx
0.00%+4.00%-35.00%-4.29%-57.84%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-7.93%-2.75%-9.42%-35.54%-77.59%
Sonendo, Inc. stock logo
SONX
Sonendo
-11.76%-10.00%-5.86%-41.90%-92.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
N/AN/AN/AN/AN/AN/AN/AN/A
BioCorRx Inc. stock logo
BICX
BioCorRx
N/AN/AN/AN/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.4733 of 5 stars
3.10.00.00.00.00.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
N/AN/AN/AN/A
BioCorRx Inc. stock logo
BICX
BioCorRx
N/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
2.25
Hold$1.881,978.71% Upside

Current Analyst Ratings

Latest BICX, AIH, SONX, and MGRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2024
Sonendo, Inc. stock logo
SONX
Sonendo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 5/9/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
$96.45M0.17$0.15 per share3.50$0.15 per share3.40
BioCorRx Inc. stock logo
BICX
BioCorRx
$90K77.13N/AN/A($1.14) per share-0.68
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$730K9.11N/AN/A$0.04 per share6.75
Sonendo, Inc. stock logo
SONX
Sonendo
$43.87M0.14N/AN/A$0.45 per share0.20

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
-$5.29MN/A0.00N/AN/AN/AN/A5/15/2024 (Estimated)
BioCorRx Inc. stock logo
BICX
BioCorRx
-$3.77M-$0.45N/AN/A-4,235.96%N/A-623.19%5/13/2024 (Estimated)
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-$9.21MN/A0.00N/A-1,260.81%-411.62%-366.32%7/1/2024 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$0.65N/AN/AN/A-138.88%-121.92%-58.04%5/10/2024 (Estimated)

Latest BICX, AIH, SONX, and MGRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A-$0.11-$0.11-$0.11N/A$0.02 million
4/1/2024Q4 2023
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A-$0.13-$0.13-$0.13N/A$0.24 million
3/11/2024Q4 2023
Sonendo, Inc. stock logo
SONX
Sonendo
-$0.15-$0.12+$0.03-$0.12$11.72 million$11.69 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
N/AN/AN/AN/AN/A
BioCorRx Inc. stock logo
BICX
BioCorRx
N/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
0.93
0.27
0.23
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A
0.03
0.03
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A
3.88
3.79
Sonendo, Inc. stock logo
SONX
Sonendo
0.44
1.85
1.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
2.13%
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
56.72%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
55.10%
BioCorRx Inc. stock logo
BICX
BioCorRx
21.40%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
46.40%
Sonendo, Inc. stock logo
SONX
Sonendo
6.41%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aesthetic Medical International Holdings Group Limited stock logo
AIH
Aesthetic Medical International Holdings Group
1,28631.35 million14.08 millionNot Optionable
BioCorRx Inc. stock logo
BICX
BioCorRx
38.90 million6.99 millionNot Optionable
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
324.62 million13.20 millionNot Optionable
Sonendo, Inc. stock logo
SONX
Sonendo
20070.46 million65.94 millionNot Optionable

BICX, AIH, SONX, and MGRX Headlines

SourceHeadline
Sonendo Inc (SONX) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...Sonendo Inc (SONX) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...
finance.yahoo.com - May 9 at 5:54 AM
SONX Stock Earnings: Sonendo Misses EPS, Beats Revenue for Q1 2024SONX Stock Earnings: Sonendo Misses EPS, Beats Revenue for Q1 2024
investorplace.com - May 8 at 11:08 PM
Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset PrioritiesSonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities
finance.yahoo.com - May 8 at 7:51 PM
Sonendo, Inc. (SONX) Reports Q1 Loss, Tops Revenue EstimatesSonendo, Inc. (SONX) Reports Q1 Loss, Tops Revenue Estimates
zacks.com - May 8 at 7:36 PM
Sonendo, Inc. to Report First Quarter 2024 Financial Results on May 8, 2024Sonendo, Inc. to Report First Quarter 2024 Financial Results on May 8, 2024
businesswire.com - April 24 at 4:14 PM
Sonendo interim CFO sells shares to cover tax obligationsSonendo interim CFO sells shares to cover tax obligations
investing.com - April 18 at 10:50 AM
Sonendo (SONX) Fell in Q4 in a Challenging Macro Purchasing EnvironmentSonendo (SONX) Fell in Q4 in a Challenging Macro Purchasing Environment
finance.yahoo.com - March 28 at 10:17 AM
Sonendo CEO sells over $2,200 in company stock to cover taxesSonendo CEO sells over $2,200 in company stock to cover taxes
investing.com - March 20 at 5:27 PM
Maintaining Hold: Sonendo Struggles with Revenue Shortfalls and Uncertain OutlookMaintaining Hold: Sonendo Struggles with Revenue Shortfalls and Uncertain Outlook
markets.businessinsider.com - March 12 at 3:26 PM
Sonendo, Inc. (NYSE:SONX) Q4 2023 Earnings Call TranscriptSonendo, Inc. (NYSE:SONX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 12 at 10:25 AM
Heres what Wall Street expects from Sonendos earningsHere's what Wall Street expects from Sonendo's earnings
markets.businessinsider.com - March 11 at 11:52 PM
Sonendo Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Full Year 2024 Revenue GuidanceSonendo Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Full Year 2024 Revenue Guidance
businesswire.com - March 11 at 4:05 PM
Sonendo Announces Departure of Chief Financial OfficerSonendo Announces Departure of Chief Financial Officer
finance.yahoo.com - March 8 at 8:00 PM
Sonendo Divests TDO® Software and Amends Credit AgreementSonendo Divests TDO® Software and Amends Credit Agreement
finance.yahoo.com - March 4 at 5:54 PM
Sonendo, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024Sonendo, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
businesswire.com - March 1 at 7:00 AM
Sonendo to Participate at Upcoming Investor ConferenceSonendo to Participate at Upcoming Investor Conference
finance.yahoo.com - January 16 at 9:57 AM
Sonendo Continues Expanding the Reach of Its GentleWave Procedure; Partners with Dental Purchasing GroupSonendo Continues Expanding the Reach of Its GentleWave Procedure; Partners with Dental Purchasing Group
finance.yahoo.com - January 9 at 9:28 AM
Sonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® ProcedureSonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® Procedure
finance.yahoo.com - January 3 at 10:36 AM
Sonendo Stock (OTC:SONX) Dividends: History, Yield and DatesSonendo Stock (OTC:SONX) Dividends: History, Yield and Dates
benzinga.com - December 19 at 11:22 PM
Sonendo Shares Continue Fall; NYSE to OTCSonendo Shares Continue Fall; NYSE to OTC
ocbj.com - December 4 at 7:19 PM
NYSE to Commence Delisting Proceedings Against Sonendo, Inc. (SONX)NYSE to Commence Delisting Proceedings Against Sonendo, Inc. (SONX)
finance.yahoo.com - November 21 at 7:12 PM
Sonendo Delisted from NYSESonendo Delisted from NYSE
ocbj.com - November 21 at 7:12 PM
Sonendo, Inc. Announces Suspension of NYSE Trading, Will Commence Trading on the OTCQX Effective November 22, 2023Sonendo, Inc. Announces Suspension of NYSE Trading, Will Commence Trading on the OTCQX Effective November 22, 2023
finance.yahoo.com - November 21 at 7:12 PM
ArrowMark Colorado Holdings LLC Reduces Stake in Sonendo IncArrowMark Colorado Holdings LLC Reduces Stake in Sonendo Inc
finance.yahoo.com - November 14 at 6:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aesthetic Medical International Holdings Group logo

Aesthetic Medical International Holdings Group

NASDAQ:AIH
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and ultraviolet light treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
BioCorRx logo

BioCorRx

OTCMKTS:BICX
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Mangoceuticals logo

Mangoceuticals

NASDAQ:MGRX
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Sonendo logo

Sonendo

NYSE:SONX
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.